Vanderbilt University Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Vanderbilt University Medical Center sits in the top decile of US sponsors by registered trial count (#51 of 15,742 sponsors by registered trial count).

677 total trials 130 currently recruiting 400 completed early-phase tilt top decile by trial count

Vanderbilt University Medical Center: 677 sponsored US clinical trials, 130 recruiting.

Vanderbilt University Medical Center sponsors 677 registered US clinical trials on ClinicalTrials.gov, 130 of them currently recruiting, and 400 completed. 70 of these trials are in Phase 3-4 (later-stage) and 127 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autonomic Failure, with 9 trials.

Top-decile sponsor footprint

Vanderbilt University Medical Center ranks in the top decile of sponsors by registered trial count (#51 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 54/100

400 of 467 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

677 total, page 7 of 14

COMPLETED NA

Cognitive Behavioral Therapy (CBT) Study Evaluating the Updating of Persecutory Beliefs

NCT04748679

COMPLETED

Influence of Stress and Psychiatric Symptoms on Children With Tourette Syndrome

NCT04449003

COMPLETED Phase 2

Effect of PDE5 Inhibition on Adipose Metabolism in Humans

NCT04684589

COMPLETED NA

Preemptive Pharmacogenetic-guided Metoprolol Management for PostoperativeAtrial Fibrillation in Cardiac Surgery

NCT03943927

TERMINATED NA

Feasibility of Telehealth Mindfulness for Back Pain in the Emergency Department

NCT04783532

COMPLETED NA

Food for Thought: Virtual Home-Based Family Interventions to Improve Nutrition Behaviors

NCT05328193

COMPLETED

Neuroinflammation in Chronic Systemic Symptoms (CSS)

NCT04636723

COMPLETED NA

Early Cognitive Intervention in Delirium

NCT04740567

COMPLETED NA

Quantitation of Glymphatic Functioning in Sleep and Meditative States

NCT04506892

COMPLETED

Pediatric Type 1 Diabetes and Neurocognitive Complications Cohort Study

NCT04135365

COMPLETED NA

A Comparison of Ureteroscopic Treatment of Nephrolithiasis With and Without Moses Technology

NCT04505956

COMPLETED

4D Medical X-ray Velocimetry for Bronchoscopic Lung Volume Reduction Targeting

NCT04786171

COMPLETED Phase 2

Depressed Mood Improvement Through Nicotine Dosing 2

NCT04433767

COMPLETED NA

Investigating Biological Targets, Markers, and Intervention for Chronic Pain

NCT04625504

COMPLETED NA

Improving CarE for Community Acquired Pneumonia 1 (ICE-CAP2)

NCT06033079

COMPLETED NA

The Effect of Providing Stratification of Low Risk Penicillin Allergies on Penicillin Allergy Label Removal

NCT03702270

COMPLETED NA

Using a Real-Time Risk Prediction Model to Predict Pediatric Venous Thromboembolism (VTE) Events

NCT04574895

COMPLETED NA

The Natriuretic Peptide Response to Saline Infusion

NCT04223531

COMPLETED NA

Enhancing Social Competence in Adults With Autism

NCT04349644

COMPLETED NA

Enhanced Secondary Intention Healing vs. Standard Secondary Intention Healing in Mohs Surgical Defects on the Head and Distal Lower Extremities

NCT04545476

COMPLETED NA

Physical Activity Intervention for Patients Following Lumbar Spine Surgery

NCT04591249

COMPLETED Phase 2

Pharmacological Modulation of Hippocampal Activity in Psychosis 2

NCT04559529

TERMINATED Phase 2

Use of Autologous Platelet-Rich Plasma to Treat Hypertrophic Burn Scars

NCT03935594

COMPLETED

Feasibility Assessment of Risk Stratification and Oral Challenge in Hospitalized Children at Low Risk for Antibiotic Allergy

NCT04441021

COMPLETED

Asymptomatic Renal Calculi in Recurrent Urinary Tract Infections

NCT04495699

COMPLETED Phase 4

Exercise Pulmonary Transit Time

NCT04336995

COMPLETED

Psychosocial, Behavioral, and Radiologic Changes Following Radiosurgery for Benign Neurologic Disease

NCT04688554

COMPLETED Phase 2

A Clinical Trial Utilizing Dantrolene in Patients With Ventricular Arrhythmias.

NCT04134845

COMPLETED NA

Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 2

NCT04417218

TERMINATED NA

Lavare Cycle in Patients Receiving HeartWare Left Ventricular Assist Device

NCT04199793

COMPLETED NA

Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome

NCT04275297

COMPLETED

Establishing a Normative Database in Pediatric Population of the Head-mounted visuALL Field Analyzer

NCT04175444

COMPLETED Phase 2

Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19

NCT04372628

COMPLETED

Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic

NCT04391166

COMPLETED Phase 2

2-Hydroxybenzylamine (2-HOBA) to Prevent Early Recurrence of Atrial Fibrillation After Catheter-based Ablation

NCT04433091

TERMINATED Phase 2

Pharmacologic Modulation of Hippocampal Activity in Psychosis

NCT04277936

COMPLETED NA

Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19

NCT04347538

COMPLETED NA

Mobile Phone Support for Adults and Support Persons to Live Well With Diabetes

NCT04347291

COMPLETED NA

COVID-19 Patient Positioning Pragmatic Trial

NCT04359797

COMPLETED Phase 3

Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized Adults

NCT04362176

COMPLETED

Sensory Symptoms in Tourette Syndrome and Obsessive-Compulsive Disorder

NCT04335175

COMPLETED

The Afolabi Stroke Registry for Children and Young Adults With SCD in Northern Nigeria

NCT04800809

COMPLETED Phase 3

Efficacy and Safety of Dapagliflozin in Acute Heart Failure

NCT04298229

COMPLETED NA

Evaluation of a Patient Portal Intervention for Diabetes: A Pilot Randomized Controlled Trial

NCT03947333

COMPLETED NA

Coordinated, Collaborative, Comprehensive, Family-based, Integrated, Technology-enabled Stroke Care

NCT04000971

COMPLETED NA

Neuroplasticity-Based Cognitive Remediation for Chemotherapy-Related Cognitive Impairment

NCT04230863

COMPLETED NA

Nashville - Hypertension Management Model

NCT04232124

TERMINATED

Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease

NCT03709771

COMPLETED

Post Epidural Steroid Injection Follow-up

NCT04207606

COMPLETED NA

Advocating for Supports to Improve Service Transitions

NCT04173663

← Previous Page 7 of 14 Next →

Phase Distribution

PhaseTrial count
Phase 1 65
Phase 2 62
Phase 3 14
Phase 4 56

What is open in the Vanderbilt University Medical Center pipeline

130 recruiting of 677 indexed (19% open); 400 completed (59%).

Phase mix: 70 late (III/IV) vs 127 early (I/II) (early-phase heavy).

Top condition: Autonomic Failure (9 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Vanderbilt University Medical Center: open-pipeline peers nationwide

Peers matched on 677 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 01,0002,0003,000 12%14%16%18%20%22%24% Total trials Recruiting share Vanderbilt University Medical CenterThe Cleveland ClinicUniversity of California, DavisWeill Medical College of Cornell UniversityIcahn School of Medicine at Mount SinaiCalifornia Polytechnic State University-San Luis ObispoPhoenix Children's HospitalMayo ClinicUniversity of South Carolina
Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 677 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this Vanderbilt University Medical Center page

677 registered trials is a research-attention snapshot, not an endorsement of Vanderbilt University Medical Center or any single study.

  • 130 of Vanderbilt University Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Autonomic Failure is the condition Vanderbilt University Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autonomic Failure trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Vanderbilt University Medical Center pipeline card: 677 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.